Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
472 studies found for:    ferritin
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Recruiting Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery
Condition: Preterm Delivery
Interventions: Procedure: serum ferritin;   Procedure: MCA Doppler
3 Active, not recruiting Maternal Serum Ferritin and Low Neonatal Birth Weight
Condition: IUGR
Intervention:
4 Recruiting Glycosylated Ferritin in Macrophagic Activation Syndromes
Conditions: Still's Disease, Adult-Onset;   Sepsis;   Macrophagic Activation Syndrome
Intervention:
5 Completed DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Conditions: Anemia, Iron-Deficiency;   Kidney Failure, Chronic;   Hemodialysis
Intervention: Drug: Sodium ferric gluconate,
6 Completed Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants
Conditions: Anemia;   Ferritin;   Complications;   Hemorrhage;   Jaundice
Interventions: Procedure: Early Cord Clamping;   Procedure: Delayed Cord Clamping
7 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
8 Recruiting Hepcidine and Iron Deficiency in Critically Ill Patients
Conditions: Anemia;   Critical Illness;   Hospitalized for 5 Days or More
Interventions: Biological: hepcidin;   Biological: ferritin and transferrin saturation
9 Completed
Has Results
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Conditions: Iron Deficiency Anaemia;   Chronic Kidney Disease
Interventions: Drug: FCM (Ferric carboxymaltose) high ferritin target;   Drug: FCM (Ferric carboxymaltose) low ferritin target;   Drug: Oral Iron (Ferrous sulphate)
10 Completed The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis
Condition: Hemophagocytic Lymphohistiocytosis
Intervention:
11 Suspended Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
Condition: Latent Iron Deficiency
Interventions: Drug: Bledilait Biofer®;   Drug: Milk supplemented with ferrous sulphate;   Drug: Blédilait Biofer®
12 Completed Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?
Conditions: Atherosclerosis;   Intermittent Claudication;   Peripheral Vascular Diseases
Intervention: Procedure: Ferritin reduction to 25 ng/ml by phlebotomy
13 Unknown  Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
Conditions: Beta-thalassemia Major;   Sickle Cell Disease;   Iron Hemosiderosis
Interventions: Drug: DFP (ferriprox) and deferasirox (ICL 670);   Drug: DFP, DFO
14 Not yet recruiting An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Condition: Beta Thalassemia Major
Intervention: Drug: Deferiprone
15 Completed Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Chronic Anemia;   Transfusional Hemosiderosis
Intervention: Drug: Deferasirox (ICL670)
16 Completed Strategies to Reduce Iron Deficiency
Condition: Iron Deficiency
Interventions: Dietary Supplement: Ferrous gluconate- 19 mg;   Dietary Supplement: Ferrous gluconate- 38 mg;   Other: Letter Group- Information Provided;   Other: Letter - No Information Provided;   Dietary Supplement: Placebo
17 Completed Timing of Iron Supplementation in Very Low Birth Weight Infants
Condition: Nutritional Status
Intervention: Drug: Elemental iron
18 Completed Is Iron Deficiency the Cause of Anemia Among Women in Cambodia?
Conditions: Anemia;   Iron Deficiency;   Hemoglobin Disorder;   Infection;   Inflammation
Interventions: Dietary Supplement: Multiple micronutrients;   Dietary Supplement: Iron;   Dietary Supplement: Placebo
19 Completed The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Intervention:
20 Completed
Has Results
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Conditions: Fatigue;   Iron Deficiency
Interventions: Drug: Ferrous sulphate;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years